Fred C. Semitala • A. Musinguzi • J. L. Ssemata • F. Welishe • J. Nabunje • J. L. Kadota • Christopher A. Berger • Katamba A • Noah Kiwanuka • Moses R. Kamya • David W. Dowdy • Cattamanchi A • Katahoire Ar
(2020)
Abstract; BackgroundA 12-dose, once-weekly regimen of isoniazid and rifapentine (3HP) is effective in preventing tuberculosis (TB) among people living with HIV (PLHIV). We sought to identify potential barriers to ...